Gavi welcomes final approval of U.S. support for global immunisation in Year-End Omnibus and COVID Supplemental Package

Gavi [to 2 Jan 2021]
https://www.gavi.org/
News releases
Gavi welcomes final approval of U.S. support for global immunisation in Year-End Omnibus and COVID Supplemental Package
Geneva, 28 December 2020
:: The United States has approved US$ 4 billion for Gavi, the Vaccine Alliance to ensure lower-income economies have equitable access to safe and effective COVID-19 vaccines on the same urgent timeline as wealthier countries. These funds will help end this acute phase of the pandemic.
:: The United States also approved its Fiscal Year 2021 contribution of US$ 290 million for Gavi’s routine immunisation programmes. This funding is part of the multi-year pledge made to Gavi at the Global Vaccine Summit in June and will help provide life-saving vaccines to nearly half the world’s children.
:: Seth Berkley, CEO of Gavi: “This support from the American people will help Gavi procure and deliver COVID-19 vaccine doses for lower-income economies through the Gavi COVAX AMC. It will also shorten this crisis, save lives and help restart the global economy. In today’s interconnected world, no one is safe until everyone is safe.”